|
|
|
HPV Clinical Trials |
|
Thank you for your interest in clinical trials for HPV
Please click "Search" to find HPV clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 1 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study - NCT01133509-23507
Conditions: Human Papillomavirus (HPV)
Location: Norfolk, VA
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-10016
Conditions: Cervical Intraepithelial Neoplasia
Location: New York, NY
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-10461
Conditions: Cervical Intraepithelial Neoplasia
Location: Bronx, NY
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-19611
Conditions: Cervical Intraepithelial Neoplasia
Location: West Reading, PA
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-23502
Conditions: Cervical Intraepithelial Neoplasia
Location: Norfolk, VA
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-27103
Conditions: Cervical Intraepithelial Neoplasia
Location: Winston-salem, NC
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-28562
Conditions: Cervical Intraepithelial Neoplasia
Location: New Bern, NC
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-29201
Conditions: Cervical Intraepithelial Neoplasia
Location: Columbia, SC
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-29615
Conditions: Cervical Intraepithelial Neoplasia
Location: Greenville, SC
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-30322
Conditions: Cervical Intraepithelial Neoplasia
Location: Atlanta, GA
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-30912
Conditions: Cervical Intraepithelial Neoplasia
Location: Augusta, GA
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-33136
Conditions: Cervical Intraepithelial Neoplasia
Location: Miami, FL
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-33143
Conditions: Cervical Intraepithelial Neoplasia
Location: South Miami, FL
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-33409
Conditions: Cervical Intraepithelial Neoplasia
Location: West Palm Beach, FL
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-33461
Conditions: Cervical Intraepithelial Neoplasia
Location: Lake Worth, FL
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-34239
Conditions: Cervical Intraepithelial Neoplasia
Location: Sarasota, FL
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-35233
Conditions: Cervical Intraepithelial Neoplasia
Location: Birmingham, AL
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-36608
Conditions: Cervical Intraepithelial Neoplasia
Location: Mobile, AL
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-45322
Conditions: Cervical Intraepithelial Neoplasia
Location: Englewood, OH
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-45631
Conditions: Cervical Intraepithelial Neoplasia
Location: Gallipolis, OH
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-64139
Conditions: Cervical Intraepithelial Neoplasia
Location: Kansas City, MO
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-70072
Conditions: Cervical Intraepithelial Neoplasia
Location: Marrero, LA
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-77004
Conditions: Cervical Intraepithelial Neoplasia
Location: Houston, TX
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-78503
Conditions: Cervical Intraepithelial Neoplasia
Location: McAllen, TX
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-78705
Conditions: Cervical Intraepithelial Neoplasia
Location: Austin, TX
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-80910
Conditions: Cervical Intraepithelial Neoplasia
Location: Colorado Springs, CO
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-85015
Conditions: Cervical Intraepithelial Neoplasia
Location: Phoenix, AZ
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-85712
Conditions: Cervical Intraepithelial Neoplasia
Location: Tucson, AZ
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-85724
Conditions: Cervical Intraepithelial Neoplasia
Location: Tucson, AZ
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-89030
Conditions: Cervical Intraepithelial Neoplasia
Location: Las Vegas, NV
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-89128
Conditions: Cervical Intraepithelial Neoplasia
Location: Las Vegas, NV
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-90027
Conditions: Cervical Intraepithelial Neoplasia
Location: Los Angeles, CA
- A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection - NCT01022346-92324
Conditions: Cervical Intraepithelial Neoplasia
Location: Colton, CA
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-02906
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Providence, RI
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-15241
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Pittsburgh, PA
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-23233
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Richmond, VA
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-29425
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Charleston, SC
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-30912
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Augusta, GA
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-40202
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Louisville, KY
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-84121
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Salt Lake City, UT
- A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ - NCT01047345-93710
Conditions: Cervical Cancers - Vulvar Cancers - Vaginal Cancers - Genital Warts - Human Papillomavirus (HPV) Infection
Location: Fresno, CA
- Acceptance of Human Papillomavirus Vaccination in Postpartum Women - NCT00730704-10032
Conditions: Human Papilloma Virus - HPV - Post Partum
Location: New York, NY
- Alternate Dosing Schedules Study for HPV Vaccine - NCT00862810-27704A
Conditions: Cervical Cancer - Genital Warts
Location: Durham, NC
- Alternate Dosing Schedules Study for HPV Vaccine - NCT00862810-27704B
Conditions: Cervical Cancer - Genital Warts
Location: Durham, NC
- Alternate Dosing Schedules Study for HPV Vaccine - NCT00862810-27704C
Conditions: Cervical Cancer - Genital Warts
Location: Durham, NC
- Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers - NCT01087164-77555
Conditions: Human Papillomavirus Infection
Location: Galveston, TX
- Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? - NCT01101750-20007
Conditions: Cervical Cancer - HPV - Warts
Location: Washington, DC
- Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? - NCT01101750-20010
Conditions: Cervical Cancer - HPV - Warts
Location: Washington, DC
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-02906
Conditions: HIV Infections
Location: Providence, RI
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-07103
Conditions: HIV Infections
Location: Newark, NJ
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-10011
Conditions: HIV Infections
Location: New York, NY
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-10032
Conditions: HIV Infections
Location: New York, NY
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-14607
Conditions: HIV Infections
Location: Rochester, NY
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-14642
Conditions: HIV Infections
Location: Rochester, NY
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-19104
Conditions: HIV Infections
Location: Philadelphia, PA
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-27401
Conditions: HIV Infections
Location: Greensboro,, NC
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-27514A
Conditions: HIV Infections
Location: Chapel Hill, NC
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-27514B
Conditions: HIV Infections
Location: Chapel Hill, NC
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-27710
Conditions: HIV Infections
Location: Durham, NC
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-30308
Conditions: HIV Infections
Location: Atlanta, GA
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-33139
Conditions: HIV Infections
Location: Miami, FL
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-35294
Conditions: HIV Infections
Location: Birmingham,, AL
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-37232
Conditions: HIV Infections
Location: Nashville, TN
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-43210
Conditions: HIV Infections
Location: Colombus, OH
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-44109
Conditions: HIV Infections
Location: Cleveland, OH
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-45267
Conditions: HIV Infections
Location: Cincinnati, OH
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-60611
Conditions: HIV Infections
Location: Chicago, IL
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-60612
Conditions: HIV Infections
Location: Chicago, IL
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-63110A
Conditions: HIV Infections
Location: St. Louis, MO
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-63110B
Conditions: HIV Infections
Location: St. Louis, MO
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-92103
Conditions: HIV Infections
Location: San Diego, CA
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults - NCT01029249-94304
Conditions: HIV Infections
Location: Palo Alto, CA
- Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls - NCT00867464-20892
Conditions: Cervical Neoplasia - HPV Infections
Location: Bethesda, MD
- Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females - NCT00813319-30236
Conditions: Vaccination
Location: Jonesboro, GA
- Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females - NCT00813319-30303
Conditions: Vaccination
Location: Atlanta, GA
- Giving Immunizations Through Vaccine Education - NCT01159093-19103
Conditions: HPV Vaccines
Location: Philadelphia, PA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-10029
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: New York, NY
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-15106
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Carnegie, PA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-15236
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Pittsburgh, PA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-16507
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Erie, PA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-16508
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Erie, PA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-27514
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Chapel Hill, NC
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-33409
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: West Palm Beach, FL
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-33759
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Clearwater, FL
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-52242
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Iowa City, IA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-67207
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Wichita, KS
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-68131
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Omaha, NE
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-87131
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Albuquerque, NM
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-97210
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Portland, OR
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-98801
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Wenatchee, WA
- Human Papilloma Virus (HPV) Vaccination Commitment and Compliance Among Rural African American Primary Caregivers and Their Daughters - NCT00937287-30602
Conditions: HPV
Location: Athens, GA
- Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer - NCT00435214-94612
Conditions: Cervical Cancer - Cervical Precancer
Location: Oakland, CA
- Human Papillomavirus (HPV) Infection in Pregnancy - NCT00194311-19104
Conditions: Papillomavirus Infections - Pregnancy Complications
Location: Philadelphia, PA
- Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers - NCT00680147-13244
Conditions: HPV
Location: Syracuse, NY
- Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer - NCT01117389-38105
Conditions: Human Papillomavirus
Location: Memphis, TN
- Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test - NCT01104181-10011
Conditions: Anal Canal HPV Infection Diagnosis - Anal Dysplasia Diagnosis - Anal Cancer
Location: New York, NY
- Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women - NCT00786409-60637
Conditions: Systemic Lupus Erythematosus
Location: Chicago, IL
- Immunogenicity of Off-Schedule Dosing of HPV Vaccine - NCT01030562-15241
Conditions: Human Papillomavirus
Location: Pittsburgh, PA
- Immunogenicity of Off-Schedule Dosing of HPV Vaccine - NCT01030562-21201
Conditions: Human Papillomavirus
Location: Baltimore, MD
- Immunogenicity of Off-Schedule Dosing of HPV Vaccine - NCT01030562-30084
Conditions: Human Papillomavirus
Location: Tucker, GA
- Immunogenicity of Off-Schedule Dosing of HPV Vaccine - NCT01030562-37232
Conditions: Human Papillomavirus
Location: Nashville, TN
- Immunogenicity of Off-Schedule Dosing of HPV Vaccine - NCT01030562-45229
Conditions: Human Papillomavirus
Location: Cincinnati, OH
- Immunogenicity of Off-Schedule Dosing of HPV Vaccine - NCT01030562-64108
Conditions: Human Papillomavirus
Location: Kansas City, MO
- Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life - NCT01181648-10065
Conditions: Squamous Cell Carcinoma of the Oropharynx
Location: New York, NY
- MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck - NCT00257738-21201
Conditions: Squamous Cell Carcinoma of the Head and Neck
Location: Baltimore, MD
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-06050
Conditions: Head and Neck Cancer - Precancerous Condition
Location: New Britain, CT
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-21231
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Baltimore, MD
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-22401
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Fredericksburg, VA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-37232
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Nashville, TN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43402
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Bowling Green, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43410
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Clyde, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43537A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Maumee, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43537B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Maumee, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43560
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Sylvania, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43567
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wauseon, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43606
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Toledo, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43608
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Toledo, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43614
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Toledo, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43616A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Oregon, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43616B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Oregon, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43617
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Toledo, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43623A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Toledo, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-43623B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Toledo, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-44035A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Elyria, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-44035B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Elyria, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-44857
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Norwalk, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-44870
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Sandusky, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-44883
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Tiffin, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-45804
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Lima, OH
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-48144
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Lambertville, MI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-48162A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Monroe, MI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-48162B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Monroe, MI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-49221
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Adrian, MI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-49431
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Escanaba, MI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-49801
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Iron Mountain, MI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50309A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Des Moines, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50309B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Des Moines, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50309C
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Des Moines, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50314A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Des Moines, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50314B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Des Moines, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50316
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Des Moines, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50325A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Clive, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-50325B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Clive, IA
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-53066
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Oconomowoc, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-53188
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Waukesha, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54143
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Marinette, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54154
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Oconto Falls, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54221
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Manitowoc, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54235A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Sturgeon Bay, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54235B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Sturgeon Bay, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54301
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Green Bay, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54303A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Green Bay, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54303B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Green Bay, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-54307
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Green Bay, WI
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55101
Conditions: Head and Neck Cancer - Precancerous Condition
Location: St. Paul, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55102
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Saint Paul, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55109A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Maplewood, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55109B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Maplewood, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55125
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Woodbury, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55337
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Burnsville, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55350
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Hutchinson, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55379
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Shakopee, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55387
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Waconia, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55407
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Minneapolis, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55415
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Minneapolis, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55416A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Saint Louis Park, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55416B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Saint Louis Park, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55422
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Robbinsdale, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55432
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Fridley, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55433
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Coon Rapids, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-55435
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Edina, MN
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-66044
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Lawrence, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-66701
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Fort Scott, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-66720
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Chanute, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67042
Conditions: Head and Neck Cancer - Precancerous Condition
Location: El Dorado, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67068
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Kingman, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67114
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Newton, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67124
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Pratt, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67152
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wellington, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67156
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Winfield, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67208A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wichita, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67208B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wichita, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67214A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wichita, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67214B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wichita, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67214C
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wichita, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67301
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Independence, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67357
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Parsons, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67401
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Salina, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67801
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Dodge City, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-67905
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Liberal, KS
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80012
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Aurora, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80033
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Wheat Ridge, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80110
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Englewood, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80124
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Lone Tree, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80204
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Denver, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80210
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Denver, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80218A
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Denver, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80218B
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Denver, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80220
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Denver, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80224
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Denver, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80229
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Thornton, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80301
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Boulder, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80501
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Longmont, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80528
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Fort Collins, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80539
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Loveland, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80631
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Greeley, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-80933
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Colorado Springs, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-81502
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Grand Junction, CO
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-87131
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Albuquerque, NM
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery - NCT01084083-94305
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Stanford, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Newark, NJ
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-02114
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Boston, MA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-02115
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Boston, MA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-02118
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Boston, MA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-02906
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Providence, RI
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-10016
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: New York, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-10037
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: New York, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-10461
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: New York, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-11794
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Stony Brook, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-14642A
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Rochester, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-14642B
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Rochester, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-19104
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Philadelphia, PA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-20006
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Washington, DC
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-20060
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Washington, DC
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-21201
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Baltimore, MD
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-23219
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Richmond, VA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-27401
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Greensboro, NC
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-30308
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Atlanta, GA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-32209
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Jacksonville, FL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-33136
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Miami, FL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-35924
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Birmingham, AL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-37203
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Nashville, TN
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-38105
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Memphis, TN
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-44106
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Cleveland, OH
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-60608
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Chicago,, IL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-60611
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Chicago, IL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-60614
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Chicago, IL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-63108
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: St. Louis, MO
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-70112
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: New Orleans, LA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-77030
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Houston, TX
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-80218
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Denver, CO
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90033A
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Los Angeles, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90033B
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Los Angeles, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90095
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Los Angeles, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90806
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Long Beach, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-92103
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: San Diego, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-94110
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: San Francisco, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-94305
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Stanford, CA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-07962
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Morristown, NJ
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-10029
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: New York, NY
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|